Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct

Aatur D. Singhi, Laura D. Wood, Emma Parks, Michael S. Torbenson, Matthäus Felsenstein, Ralph H. Hruban, Marina N. Nikiforova, Abigail I. Wald, Cihan Kaya, Yuri E. Nikiforov, Laura Favazza, Jin He, Kevin McGrath, Kenneth E. Fasanella, Randall E. Brand, Anne Marie Lennon, Alessandro Furlan, Anil K. Dasyam, Amer H. Zureikat, Herbert J. ZehKenneth Lee, David L. Bartlett, Adam Slivka

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Background & Aims: Intraductal oncocytic papillary neoplasms (IOPNs) of the pancreas and bile duct contain epithelial cells with numerous, large mitochondria and are cystic precursors to pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CCA), respectively. However, IOPNs do not have the genomic alterations found in other pancreatobiliary neoplasms. In fact, no recurrent genomic alterations have been described in IOPNs. PDACs without activating mutations in KRAS contain gene rearrangements, so we investigated whether IOPNs have recurrent fusions in genes. Methods: We analyzed 20 resected pancreatic IOPNs and 3 resected biliary IOPNs using a broad RNA-based targeted sequencing panel to detect cancer-related fusion genes. Four invasive PDACs and 2 intrahepatic CCAs from the same patients as the IOPNs, were also available for analysis. Samples of pancreatic cyst fluid (n = 5, collected before surgery) and bile duct brushings (n = 2) were analyzed for translocations. For comparison, we analyzed pancreatobiliary lesions from 126 patients without IOPN (controls). Results: All IOPNs evaluated were found to have recurring fusions of ATP1B1–PRKACB (n = 13), DNAJB1–PRKACA (n = 6), or ATP1B1–PRKACA (n = 4). These fusions also were found in corresponding invasive PDACs and intrahepatic CCAs, as well as in matched pancreatic cyst fluid and bile duct brushings. These gene rearrangements were absent from all 126 control pancreatobiliary lesions. Conclusions: We identified fusions in PRKACA and PRKACB genes in pancreatic and biliary IOPNs, as well as in PDACs and pancreatic cyst fluid and bile duct cells from the same patients. We did not identify these gene fusions in 126 control pancreatobiliary lesions. These fusions might be used to identify patients at risk for IOPNs and their associated invasive carcinomas.

Original languageEnglish (US)
Pages (from-to)573-582.e2
Issue number3
StatePublished - Feb 2020


  • CCA
  • Diagnostic Factor
  • Kinase A
  • Liver

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct'. Together they form a unique fingerprint.

Cite this